⌕
Beam Therapeutics · BEAM · Nasdaq
Tenet 61 · Solid
Compare
$20.65−1.38%At closeTenet 61 · Solid
$20.65−0.29 (−1.38%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Beam Therapeutics (BEAM) Institutional Ownership

13F filers reported holding 34.7% of Beam Therapeutics (BEAM) shares as of Sep 30, 2026, across 149 filers.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice
Held by 13F filers
34.7%
Sep 30, 2026
13F filers
149
quarter ended Sep 30, 2026
13F value
$877.7M
35.9M shares
Quarter's fund flow
Mild distribution
18 new · 28 closed

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

13F fund flowQuarter ended Sep 30, 2026: more funds trimmed or exited than added or entered, mild distribution (18 new · 52 increased · 51 reduced · 28 closed). Flows at this scale move slowly; treat as context. These positions are 49 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
Basis: shares reported by 149 13F filers for Sep 30, 2026, over shares outstanding implied from the current quote, measured 49 days apart. It measures the ownership we have filings for, not total institutional ownership, and it moves with the share count between filings.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Oct 16, 2026Evans John M.CEOAcquired · Option exercise25,000$1.03↗
Oct 16, 2026Evans John M.CEODisposed · Open-market sale25,000$23.98↗
Oct 16, 2026Evans John M.CEODisposed · Option exercise25,000Stock Option (Right to Buy)—↗
Oct 15, 2026Evans John M.CEOAcquired · Option exercise25,000$1.03↗
Oct 15, 2026Evans John M.CEODisposed · Open-market sale25,000$23.57↗
Oct 15, 2026Evans John M.CEODisposed · Option exercise25,000Stock Option (Right to Buy)—↗
Oct 1, 2026Cavanagh Bethany JSVP, Finance and TreasurerDisposed · Open-market sale187$24.41↗
Jul 27, 2026Simon AmyChief Medical OfficerDisposed · Open-market sale16,667$25.74↗
Jun 30, 2026Simon AmyChief Medical OfficerDisposed · Open-market sale373$34.73↗
Jun 30, 2026Evans John M.CEOAcquired · Option exercise25,000$1.03↗
Jun 30, 2026Evans John M.CEODisposed · Open-market sale23,100$34.26↗
Jun 30, 2026Evans John M.CEODisposed · Open-market sale1,900$34.84↗
Jun 30, 2026Evans John M.CEODisposed · Option exercise25,000Stock Option (Right to Buy)—↗
Jun 29, 2026Evans John M.CEOAcquired · Option exercise18,663$0.67↗
Jun 29, 2026Evans John M.CEOAcquired · Option exercise6,337$1.03↗
Jun 29, 2026Evans John M.CEODisposed · Open-market sale13,421$35.13↗
Jun 29, 2026Evans John M.CEODisposed · Open-market sale11,579$35.91↗
Jun 29, 2026Evans John M.CEODisposed · Option exercise18,663Stock Option (Right to Buy)—↗
Jun 29, 2026Evans John M.CEODisposed · Option exercise6,337Stock Option (Right to Buy)—↗
Jun 26, 2026FMR LLC10% ownerDisposed · Open-market sale251,488$35.26↗

* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How much of Beam Therapeutics do institutions hold?

13F filers reported holding 34.7% of Beam Therapeutics' shares as of Sep 30, 2026, across 149 filers.

How many 13F filers hold Beam Therapeutics?

Beam Therapeutics was held by 149 13F filers as of Sep 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.